BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23752880)

  • 1. Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer.
    Farrell JJ; Toste P; Wu N; Li L; Wong J; Malkhassian D; Tran LM; Wu X; Li X; Dawson D; Wu H; Donahue TR
    Am J Gastroenterol; 2013 Aug; 108(8):1352-9. PubMed ID: 23752880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.
    Yip-Schneider MT; Wu H; Dumas RP; Hancock BA; Agaram N; Radovich M; Schmidt CM
    J Am Coll Surg; 2014 Apr; 218(4):608-17. PubMed ID: 24491241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of K-ras mutation and carcinoembryonic antigen in pancreatic cyst fluid.
    Talar-Wojnarowska R; Pazurek M; Durko L; Degowska M; Rydzewska G; Smigielski J; Janiak A; Olakowski M; Lampe P; Grzelak P; Stefanczyk L; Smolarz B; Malecka-Panas E
    Pancreatology; 2012; 12(5):417-20. PubMed ID: 23127529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts.
    Hong SK; Loren DE; Rogart JN; Siddiqui AA; Sendecki JA; Bibbo M; Coben RM; Meckes DP; Kowalski TE
    Gastrointest Endosc; 2012 Apr; 75(4):775-82. PubMed ID: 22317883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.
    Cuoghi A; Farina A; Z'graggen K; Dumonceau JM; Tomasi A; Hochstrasser DF; Genevay M; Lescuyer P; Frossard JL
    J Proteome Res; 2011 May; 10(5):2664-70. PubMed ID: 21425880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
    Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
    Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions.
    Wang J; Paris PL; Chen J; Ngo V; Yao H; Frazier ML; Killary AM; Liu CG; Liang H; Mathy C; Bondada S; Kirkwood K; Sen S
    Cancer Lett; 2015 Jan; 356(2 Pt B):404-9. PubMed ID: 25304377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas.
    Henry JC; Bassi C; Giovinazzo F; Bloomston M
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S661-6. PubMed ID: 23884752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions.
    Boot C
    Ann Clin Biochem; 2014 Mar; 51(Pt 2):151-66. PubMed ID: 24097809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyst fluid metabolites distinguish malignant from benign pancreatic cysts.
    Shi J; Yi Z; Jin L; Zhao L; Raskind A; Yeomans L; Nwosu ZC; Simeone DM; Lyssiotis CA; Stringer KA; Kwon RS
    Neoplasia; 2021 Nov; 23(11):1078-1088. PubMed ID: 34583246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.
    Ryu JK; Matthaei H; Dal Molin M; Hong SM; Canto MI; Schulick RD; Wolfgang C; Goggins MG; Hruban RH; Cope L; Maitra A
    Pancreatology; 2011; 11(3):343-50. PubMed ID: 21757972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
    JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management.
    Leung KK; Ross WA; Evans D; Fleming J; Lin E; Tamm EP; Lee JH
    Ann Surg Oncol; 2009 Oct; 16(10):2818-24. PubMed ID: 19536601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
    Maker AV; Hu V; Kadkol SS; Hong L; Brugge W; Winter J; Yeo CJ; Hackert T; Büchler M; Lawlor RT; Salvia R; Scarpa A; Bassi C; Green S
    J Am Coll Surg; 2019 May; 228(5):721-729. PubMed ID: 30794864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
    Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A
    Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
    Jabbar KS; Verbeke C; Hyltander AG; Sjövall H; Hansson GC; Sadik R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt439. PubMed ID: 24523528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PANDA cyst-fluid analysis: eats, shoots and leaves?
    Anderson MA; Kwon RS; Scheiman JM
    Gastrointest Endosc; 2009 May; 69(6):1103-5. PubMed ID: 19410042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.